Fluorodeoxyglucose positron emission tomography in leiomyosarcoma: imaging characteristics
- 1 July 2009
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Nuclear Medicine Communications
- Vol. 30 (7), 546-549
- https://doi.org/10.1097/mnm.0b013e32832bcaec
Abstract
Objective Leiomyosarcoma, a malignant neoplasm of smooth muscle, accounts for 7% of the sarcomas. Patients with leiomyosarcoma tumors have an average survival of 5 years. These tumors, which are derived from mesenchymal tissues, are difficult to diagnose, and treatment options remain controversial. The relatively rare incidence of this soft tissue sarcoma subtype has limited the number of patients available for studies and research. This study examines whether the imaging characteristics of positron emission tomography (PET) with radiolabeled fluorodeoxyglucose (FDG) provide a reliable, noninvasive means to predict tumor behavior in patients with leiomyosarcomas. Methods [18F]-FDG-PET was performed on the tumors of participating patients before the neoadjuvant chemotherapy or resection, and a maximum tumor standard uptake value (SUVmax) was calculated. Results The SUVmax was correlated with tumor grade (P=0.001) and tumor size as greatest dimension (P=0.004). Analysis of these data indicated the potential effectiveness of FDG-PET imaging in predicting tumor grade. Conclusion In leiomyosarcoma, the SUVmax from FDG-PET is a likely predictor of tumor behavior. The results of this study suggest that a large (by greatest dimension) intermediate grade tumor is expected to have the same predicted outcome as a high-grade tumor and should be treated in the same manner, as they share the same prognosis by definition of tumor grade. Improvements made in the clinical treatment of leiomyosarcomas by use of FDG-PET imaging data may lead to an increase in patient survival.Keywords
This publication has 19 references indexed in Scilit:
- Risk Assessment Based on FDG-PET Imaging in Patients with Synovial SarcomaClinical Orthopaedics and Related Research, 2008
- Epithelioid leiomyosarcoma with rhabdoid featuresWiener klinische Wochenschrift, 2007
- Ratio of the Maximum Standardized Uptake Value on FDG-PET of the Mediastinal (N2) Lymph Nodes to the Primary Tumor May Be a Universal Predictor of Nodal Malignancy in Patients With Nonsmall-Cell Lung CancerThe Annals of Thoracic Surgery, 2007
- Risk assessment in liposarcoma patients based on FDG PET imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- [18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of TumorsJournal of Clinical Oncology, 2005
- Uterine leiomyosarcoma metastatic to the sphenoid sinus: a case report and review of the literatureGynecologic Oncology, 2004
- FDG PET imaging for grading and prediction of outcome in chondrosarcoma patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Hepatic Metastases From LeiomyosarcomaAnnals of Surgery, 2000
- Positron Emission Tomography in Grading Soft Tissue SarcomasSeminars in Musculoskeletal Radiology, 1999